title: Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis.
abstract: We have studied 27 insulin-dependent diabetic patients since diagnosis for a period of six months; at diabetes onset and later on, ICA were found in 17 of them, whereas they were undetectable in 10 patients: age was remarkably homogeneous in the two groups. At diabetes onset, no significant differences were found in insulin requirement between ICA positive and ICA negative patients; however, six months after diagnosis, we observed that insulin requirement to keep metabolic control was significantly higher in ICA positive than in ICA negative subjects (0.515 +/- 0.2 U/Kg versus 0.22 +/- 0.15 U/Kg, p less than 0.001). Only one remission has been detected in ICA positive group (insulin requirement less than 0.25 U/Kg), while four ICA negative patients had complete remission and three had partial remission. ICA positive patients showed fasting C-peptide values higher than ICA negative (0.5 +/- 0.28 ng/ml versus 1.4 +/- 0.5 ng/m.; p less than 0.001, at rest; 1.1 +/- 0.6 ng/ml; versus 2.6 +/- 1.0 ng/ml, 6 minutes after stimulus; p less than 0.05). Our study suggests that presence and persistence of ICA may be considered an early and predictive marker for a worse beta cell function restoration resulting in a higher insulin requirement.
authors.affiliation: Department of Medicine, Catholic University of Sacred Heart, Rome, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Manna
authors.forename: M
authors.initials: M
authors.lastname: Salvatore
authors.forename: F
authors.initials: F
authors.lastname: Scuderi
authors.forename: G
authors.initials: G
authors.lastname: Papa
authors.forename: G
authors.initials: G
authors.lastname: Marietti
authors.forename: A V
authors.initials: AV
authors.lastname: Greco
authors.forename: G
authors.initials: G
authors.lastname: Ghirlanda
authors.forename: G
authors.initials: G
authors.lastname: Gambassi
mesh_terms: D000293:Adolescent; D001323:Autoantibodies / Q000032:analysis*; D002096:C-Peptide / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000276:immunology*; D008297:Male
chemical_list: D001323:Autoantibodies; D002096:C-Peptide; D006680:HLA Antigens; D007328:Insulin; C024211:islet cell antibody